Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Tiga TX develops an IgA therapeutic monoclonal antibody platform for the treatment of solid tumors.
We help healthcare and life sciences organizations to accelerate evidence-based decisions using real-world data, AI, and outcomes research.
Previse is a life sciences company focused on the development and commercialization of diagnostic tests for cancer prevention.
Palm Therapeutics is a next-generation therapeutics company to cure cancer at its source.
Ananya Health develops a medical device for treating cervical pre-cancer.
Voximetry is a healthtech software company that aims to give many cancer patients an alternative to chemotherapy.
Matter Bio operates as company focus on preserving genome integrity.
Microvascular Therapeutics is a biotechnology company specializing in ultrasound contrast and theranostics for diagnosis.
Modifi Biosciences is a direct DNA modification developing novel cancer therapeutics.
Saros Therapeutics is working to enhance patients' response to immunotherapy.
Current Surgical is a surgical device company that develops precise tools for the treatment of solid tumors.
Histolix provides an intrinsically digital and slide-free histopathology solution.
Helocyte is a clinical-stage biopharmaceutical company developing novel immunotherapies for the prevention and treatment of cancer.
Reveal Pharmaceuticals is the gadolinium free MRI contrast agent.
Georgia Cancer Center provides industry-leading cancer research and care that benefits patients locally and globally.
Isabl develops cancer diagnostic tests based on whole genome and RNA sequencing data.
GigaMune is a biotech firm focused on engineered TCR-Treg cell therapies for autoimmune diseases, including Type 1 Diabetes.
We are exosomes! We can extract any species of pure, viable, in-tact exosome from any biofluid source into pure solution.
OnLume provides intuitive and ergonomic solutions for the integration of precise fluorescence image-guided surgery.
Kovina Therapeutics operates as a pre-clinical biotechnology company.
Monon Bioventures is a privately held company created to assist world-class investigators
Olive Oil is a biotechnology company that produces extra virgin olive oil.
Telehealth Research Center of Excellence is a cancer center that is engaged in improving cancer-related care and outcomes.
AUM LifeTech is a Philadelphia based biotechnology company with a revolutionary nucleic acids platform.
National Cancer Institute has invested in 102 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Cancer Institute's top investment sectors include Biotechnology, Health Care, Medical, Life Science, Therapeutics. The firm invests across 23 different industry categories.
Among tracked funding rounds, Tiga TX received $35.5M in a Grant round. National Cancer Institute's total known invested capital is $325.9M.
National Cancer Institute's average investment size is $3.4M across its portfolio of 102 companies.
Recent National Cancer Institute portfolio additions include Tiga TX, Polygon Health Analytics, Previse, Palm Therapeutics, Ananya Health. These companies were founded in 2020 or later.